Macrophage-mimic shape changeable nanomedicine retained in tumor for multimodal therapy of breast cancer
R Liu, Y An, W Jia, Y Wang, Y Wu, Y Zhen, J Cao… - Journal of Controlled …, 2020 - Elsevier
The current nanomedicines for cancer therapy based on the enhance permeability and
retention (EPR) effect remain insufficient to satisfy the clinical need, and the challenges …
retention (EPR) effect remain insufficient to satisfy the clinical need, and the challenges …
Macrophage-mimic shape changeable nanomedicine retained in tumor for multimodal therapy of breast cancer.
R Liu, Y An, W Jia, Y Wang, Y Wu, Y Zhen… - Journal of Controlled …, 2020 - europepmc.org
The current nanomedicines for cancer therapy based on the enhance permeability and
retention (EPR) effect remain insufficient to satisfy the clinical need, and the challenges …
retention (EPR) effect remain insufficient to satisfy the clinical need, and the challenges …
Macrophage-mimic shape changeable nanomedicine retained in tumor for multimodal therapy of breast cancer
R Liu, Y An, W Jia, Y Wang, Y Wu… - … : official journal of …, 2020 - pubmed.ncbi.nlm.nih.gov
The current nanomedicines for cancer therapy based on the enhance permeability and
retention (EPR) effect remain insufficient to satisfy the clinical need, and the challenges …
retention (EPR) effect remain insufficient to satisfy the clinical need, and the challenges …